Are vaccines already helping contain COVID-19? Early signs say yes, but mutations will be challenging
Infection rates have declined in countries that have inoculated a large share of the population
Scientific innovation in 2021: Lessons from COVID-19
One of the bigger learnings of 2020 was that it takes time, planning, trust and bringing together of resources as well as knowledge to manage a …
Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?
The efficacy of the vaccine was 89 per cent in United Kingdom and 60 per cent in South Africa
Most of us support mandatory vaccines for schoolkids, but is it good policy?
Overwhelming scientific evidence proves the safety and efficacy of vaccination to control, yet Canada is not meeting its childhood-vaccination targets
China shifts focus to variant-specific vaccines as it faces an imminent Omicron wave
XBB subvariant has potential to wreak more havoc in China as large number of people immunologically susceptible
India to be 'leading manufacturer' of Russia’s 'doubtful' trial vaccine
Experts caution Indian government against hastened response; Russia researchers claim their vaccine is the best
How ‘good’ does a COVID-19 vaccine need to be? A new study has answers
A vaccine with an efficacy as low as 60% could still stop the pandemic. However, most, if not all of the population, would have to be vaccinated
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
COVID-19: Activists slam Centre’s affidavit washing hands off compensation for vaccine mortality
There was a huge lack of transparency about vaccine-related complications in the government’s awareness campaigns, activists said
Can nasal vaccines shield against breakthrough infections?
New study argues that nasal vaccines may be necessary to achieve more robust immunity and protection from reinfection by future variants
Clever coronavirus: Spike mutations help Omicron dodge antibodies
Research findings can help developers of vaccines, treatments understand what part of novel coronavirus to target
WHO’s urgent call: World needs new antimicrobial resistance vaccines
Urges equitable and global access to existing vaccines as well
Polio virus in sewage sample again: This time in UK
The detection signals spread between closely-linked individuals who were administered an oral polio vaccine overseas
Current monkeypox nomenclature is stigmatising: Experts
Scientists in advanced discussion with World Health Organization to adopt neutral language for monkeypox
Measles cases double in 1st 2 months of 2022: What does this warn us of
Conditions ripe for serious outbreaks of vaccine-preventable illnesses: WHO, UNICEF
COVID-19: Next virus could be worse, AstraZeneca vaccine creator Sarah Gilbert says
Research that has not been peer reviewed says that Omicron may be more infectious, but not severe
Omicron threat: How fast is India vaccinating against COVID-19
Rate too slow to meet target of vaccinating every eligible by end of year. The question is: Can Omicron further derail India’s fight …
COVID-19 vaccines produce T-cell immunity that lasts and works against virus variants
Vaccines train the immune system to recognise and respond to a particular pathogen, without first having to be infected by it
COVID-19: How the state can make vaccinating transgenders easier
The central and the state governments must look after the community, with creative leadership and broad involvement of the community
Governance matters: COVID-19 pandemic shows how
India’s shame is not the virus but the fact that we do so little to provide healthcare even in normal times
We will continue, let govt set up COVID-testing centres here: Farmers protesting at Delhi’s borders
Farm leaders ask protestors to beware of COVID-19 while plannign to beef up protests
COVID-19 vaccines: Is foreign good for India
The decision to allow foreign vaccines in India may not take plug the current shortage
New COVID-19 variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’
At least 3 documented SARS-CoV-2 variants of concern can reinfect recovered patients and vaccinated individuals
One year since we first reported on this coronavirus — what we’ve learned and still need to know
We must identify the origin of SARS-CoV-2 to prevent the continued spill-over of similar viruses into humans
Bhopal Covaxin trial participants allege side-effects, irregularities
Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there
